Jan Frayne

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2023
Publications (10 Years): 7

Top Venues

Blood

Nature communications

Blood advances

Stem cell research & therapy

University of Bristol

University of Bristol (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

University of Bristol Aug 01 2018

United Kingdom

Professor :: Biochemistry

University of Bristol Aug 01 2014 - Jul 31 2018

United Kingdom

Reader :: Biochemistry

University of Bristol Aug 01 2010 - Jul 31 2014

United Kingdom

Senior Teaching Fellow :: Biochemistry

University of Bristol Aug 01 2005 - Jul 31 2010

United Kingdom

Senior Lecturer :: Biochemistry

University of Bristol Aug 01 2000 - Jul 31 2005

United Kingdom

Lecturer :: Biochemistry

University of Bristol Aug 01 1998 - Jul 31 2000

United Kingdom

University Research Fellow :: Biochemistry

University of Bristol Aug 01 1995 - Jul 31 1998

United Kingdom

Research Associate :: Biochemistry

University of Bristol Jan 01 1995 - Jul 31 1995

United Kingdom

Temporary Lecturer :: Anatomy

University of Bristol Mar 01 1992 - Dec 31 1994

United Kingdom

Research Assistant :: Anatomy

University of Cambridge Dec 01 1984 - Dec 31 1988

United Kingdom

Research Assistant

Education History

University of Bristol Jan 01 1989 - Dec 31 1991

United Kingdom

PHD

University of Nottingham Jan 09 1981 - Jul 01 1984

United Kingdom

BSC

Publications

Ivan Ferrer-Vicens, Daniel C J Ferguson, Marieangela C Wilson, Kate J Heesom, James J Bieker, Jan Frayne
Novel human cellular model of CDA IV enables comprehensive analysis revealing molecular basis of disease phenotype. Blood (2023)
Ivan Ferrer-Vicens, Daniel C J Ferguson, Marieangela C Wilson, Kate J Heesom, James J Bieker, Jan Frayne
Novel human cellular model of CDA IV enables comprehensive analysis revealing molecular basis of disease phenotype. Blood (2023)
Ivan Ferrer-Vicens, Daniel C J Ferguson, Marieangela C Wilson, Kate J Heesom, James J Bieker, Jan Frayne
Novel human cellular model of CDA IV enables comprehensive analysis revealing molecular basis of disease phenotype. Blood (2023)
Ivan Ferrer-Vicens, Daniel C J Ferguson, Marieangela C Wilson, Kate J Heesom, James J Bieker, Jan Frayne
Novel human cellular model of CDA IV enables comprehensive analysis revealing molecular basis of disease phenotype. Blood (2023)
Deborah E Daniels, Ivan Ferrer-Vicens, Joseph Hawksworth, Tatyana N Andrienko, Elizabeth M Finnie, Natalie S Bretherton, Daniel C J Ferguson, Ana Sofia F Oliveira, Jenn-Yeu A Szeto, Marieangela C Wilson, John N Brewin, Jan Frayne
Human cellular model systems of β-thalassemia enable in-depth analysis of disease phenotype. Nature communications 14 (1) (2023)
Darya Deen, Falk Butter, Deborah E Daniels, Ivan Ferrer-Vicens, Daniel C J Ferguson, Michelle L Holland, Vasiliki Samara, Jacqueline A Sloane-Stanley, Helena Ayyub, Matthias Mann, Jan Frayne, David Garrick, Douglas Vernimmen
Identification of the transcription factor MAZ as a regulator of erythropoiesis. Blood advances 5 (15) (2021)
Kongtana Trakarnsanga, Daniel Ferguson, Deborah E Daniels, Rebecca E Griffiths, Marieangela C Wilson, Kathryn E Mordue, Abi Gartner, Tatyana N Andrienko, Annabel Calvert, Alison Condie, Angela McCahill, Joanne C Mountford, Ashley M Toye, David J Anstee, Jan Frayne
Vimentin expression is retained in erythroid cells differentiated from human iPSC and ESC and indicates dysregulation in these cells early in differentiation. Stem cell research & therapy 10 (1) (2019)

Jan Frayne.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Jan Frayne